<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0034">
 <label>34</label>
 <mixed-citation publication-type="other" id="othref0006">WHO. WHO recommends dolutegravir as preferred HIV treatment option in all populations. Published2019. 
  <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/detail/22-07-2019-who-recommends-dolutegravir-as-preferred-hiv-treatment-option-in-all-populations" id="interref0008" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.who.int/news-room/detail/22-07-2019-who-recommends-dolutegravir-as-preferred-hiv-treatment-option-in-all-populations</ext-link>
 </mixed-citation>
</ref>
